This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • An open label, one-arm, multiple dose study in pat...
Clinical trial

An open label, one-arm, multiple dose study in patients with prostate cancer to demonstrate efficacy of a one month goserelin 3.6 mg implant in a two months treatment (2 application periods) and PK/PD analysis of Zoladex� 3.6 mg implant in additional 12 p

Read time: 1 mins
Last updated:8th Aug 2011
To demonstrate that Acino Goserelin 3.6 mg implant is effective in achieving and maintaining castration levels of testosterone.
Category Value
Study start date 2011-08-08

View full details